ImmunityBio Sees Booster Role For Under-The-Tongue COVID-19 Vaccine
Novel Vaccine Focused On T-Cell Immunity
Executive Summary
In search of a differentiated approach, ImmunityBio’s candidate aims to boostT-cell immune responses via a subcutaneous and oral vaccine combination.
You may also be interested in...
To Boost Or Not To Boost? Pfizer At Odds With US FDA
US regulators indicate that authorizing booster shots is not a priority - but Pfizer still plans to seek an EUA in the fall.
Altimmune Hit By Nasal COVID-19 Vaccine Failure, But Has A Plan B
Altimmune’s hopes of bringing a nasal COVID-19 vaccine to market have been dashed, but it is pivoting to novel peptide-based therapies.
After Years Of Setbacks, Marinus Closes In On Rare Epilepsy Opportunity
After multiple failed attempts to treat rare conditions, Marinus is on the cusp of success with ganaxolone in genetic epilepsy, and has secured a new European partner in Orion.